SCHEMBL30938985

SCHEMBL30938985

CC(C)(C)OC(=O)N1CCN(c2cc(CO)c(C(=O)O)cc2F)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.52
ALDH1A1 P00352 8/20 0.52
HTT P42858 4/20 0.52
LMNA P02545 4/20 0.49
MAPK1 P28482 2/20 0.49
CASP1 P29466 1/20 0.49
CASP7 P55210 1/20 0.49
SMN1; SMN2 Q16637 4/20 0.46
HPGD P15428 3/20 0.45
ALOX15 P16050 2/20 0.45
TSHR P16473 2/20 0.45
HSD17B10 Q99714 2/20 0.45
KDM4E B2RXH2 1/20 0.45
POLB P06746 1/20 0.45
GAA P10253 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.44
GPR119 Q8TDV5 2/20 0.43
NPC1 O15118 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
MEN1 O00255 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20231932 1.00 MAPT (0.52) MAPTALDH1A1HTTLMNAMAPK1
SCHEMBL20231922 0.89 MAPT (0.50) MAPTALDH1A1HTTLMNAMAPK1
SCHEMBL710108 0.87 ALDH1A1 (0.51) MAPTALDH1A1HTTLMNAMAPK1
SCHEMBL20521398 0.84 SMN1; SMN2 (0.49) MAPTALDH1A1HTTLMNAMAPK1
SCHEMBL30221908 0.84 SMN1; SMN2 (0.49) MAPTALDH1A1HTTLMNAMAPK1
SCHEMBL23703376 0.81 SUV39H2 (0.47) MAPTALDH1A1HTTLMNAMAPK1
SCHEMBL19063936 0.81 MAPT (0.63) MAPTALDH1A1LMNASMN1; SMN2GAA
SCHEMBL21937028 0.81 MAPT (0.51) MAPTALDH1A1HTTLMNAMAPK1
SCHEMBL20046702 0.80 LMNA (0.52) MAPTALDH1A1HTTLMNASMN1; SMN2
SCHEMBL8257373 0.79 ALDH1A1 (0.60) MAPTALDH1A1HTTLMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630414-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN Captor Therapeutics S.A. (PL) 2025-10-15 EP disclosed
WO-2024121256-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2024-06-13 WO disclosed